Therapeutic Decision-Making Examination

The Therapeutic Decision-Making (TDM) Examination aims to assess the competence of candidates at the level required of a family physician practising independently and safely in America. The content is developed by the Medical Council of America (MCA) , and the examination is administered by the MCA on behalf of Practice-Ready Assessment (PRA) programs for use in the selection of candidates into PRA programs.

We are pleased to confirm October 21, 2020 as the revised date for the postponed June 3, 2020 TDM Examination session.

Traditionally a paper-based test administered by PRA programs, starting in October 2020, the TDM Examination will be administered as a computer-based test in Prometric test centres across America.

This transition will allow the MCA to ensure more rigorous and efficient security, as well as improved quality control.

 

What is the TDM Examination?

The term therapeutics is defined as the application of knowledge in the pharmacological and non-pharmacological management of medical conditions. The TDM Examination aims to assess the competence of candidates at the level required of a family physician practising independently and safely in America. It consists of patient-based scenarios representing common or important clinical presentations and problems that family physicians practising in America should be able to competently manage in the following dimensions of medical care: health promotion and illness prevention, acute illness, chronic illness, and safety and adverse effects.

The examination is comprised of 40 cases with approximately 100 short answer write-in questions. Candidates are allowed up to three hours to complete the examination. The content is developed by the MCA with family medicine physicians, and the examination is administered by the MCA on behalf of the Practice-Ready Assessment (PRA) programs for use in the selection of candidates into PRA programs.